{"gene":"DAZAP1","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2001,"finding":"DAZAP1 was identified as a protein that interacts with the male infertility factors DAZ and DAZL through yeast two-hybrid and in vitro binding assays; it contains two RNA-binding domains (RBDs) and a proline-rich C-terminal region, and while predominantly cytoplasmic, it is not associated with polyribosomes.","method":"Yeast two-hybrid, in vitro binding, subcellular fractionation, Western blot","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in single study, foundational interaction paper","pmids":["11604102"],"is_preprint":false},{"year":2004,"finding":"Mouse DAZAP1/Prrp shows dynamic intranuclear and subcellular localization changes during spermatogenesis (nuclear in pre-meiotic cells and round spermatids, cytoplasmic in elongating spermatids), and the C-terminal proline-rich region is required for nuclear import.","method":"Immunohistochemistry with monoclonal antibody, mutagenesis, subcellular localization assays","journal":"Archives of histology and cytology","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional mutagenesis in single study","pmids":["15700540"],"is_preprint":false},{"year":2005,"finding":"DAZAP1 interacts with DAZL protein in ovarian luteal cells as demonstrated by co-immunoprecipitation from ovarian tissue.","method":"Co-immunoprecipitation from rat and human ovarian tissue","journal":"Fertility and sterility","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP from tissue, no functional follow-up","pmids":["16209998"],"is_preprint":false},{"year":2005,"finding":"The MEF2D/DAZAP1 fusion protein (created by t(1;19) translocation) binds DNA in a manner indistinguishable from native MEF2D and acts as a substantially more potent transcriptional activator than MEF2D; the reciprocal DAZAP1/MEF2D fusion retains sequence-specific RNA-binding activity.","method":"DNA-binding assays, transcriptional activation assays, RNA-binding assays in leukemia cell line","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays on fusion proteins in a single study","pmids":["15744350"],"is_preprint":false},{"year":2006,"finding":"DAZAP1 is phosphorylated by ERK2 at two Thr-Pro sequences (Thr269 and Thr315) in response to PMA, EGF, or LPS via the MKK1/ERK pathway; phosphorylation at these sites causes DAZAP1 to dissociate from its binding partner DAZ, and DAZ cannot simultaneously bind both DAZAP1 and PABP.","method":"In vitro kinase assay with ERK2, site-directed mutagenesis (T269D, T315D), co-immunoprecipitation, inhibitor experiments (PD184352, U0126)","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis plus cellular validation with inhibitors","pmids":["16848763"],"is_preprint":false},{"year":2006,"finding":"DAZAP1 shuttles between the nucleus and cytoplasm via a novel 25-amino acid C-terminal segment (ZNS); nuclear localization depends on active RNA polymerase II transcription; DAZAP1 co-localizes with hnRNP A1 and hnRNP C1 and is a component of hnRNP particles.","method":"Immunostaining, heterokaryon formation assay, mutagenesis, RNA polymerase II inhibitor (actinomycin D), GFP/DsRed fusion constructs","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (heterokaryon, mutagenesis, inhibitor) in single study","pmids":["16772659"],"is_preprint":false},{"year":2007,"finding":"Both MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins transform NIH 3T3 cells (soft agar colony formation); co-expression is synergistic; wild-type DAZAP1 expression enables 3T3 cell proliferation under low serum and suppresses apoptosis.","method":"Retroviral gene transfer, soft agar colony formation assay, low-serum proliferation assay, apoptosis assay","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays with defined cellular phenotypes","pmids":["17898785"],"is_preprint":false},{"year":2008,"finding":"DAZAP1 binds to a T6 mutant BRCA1 exon 18 sequence that creates an exonic splicing silencer, and siRNA depletion of DAZAP1 reduces skipping of exon 18, demonstrating DAZAP1's role in splicing inhibition at this element alongside hnRNPA1/A2.","method":"RNA pulldown assay, siRNA knockdown, minigene splicing reporter, overexpression","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (pulldown, siRNA, minigene) with rigorous controls","pmids":["18391021"],"is_preprint":false},{"year":2008,"finding":"DAZAP1 is an hnRNP protein required for normal growth and spermatogenesis in mice; loss-of-function causes spermatogenic arrest before meiotic division (absence of post-meiotic haploid cells), growth retardation, and female infertility; DAZAP1 is excluded from the transcriptionally inactive XY body in pachytene spermatocytes.","method":"Knockout/hypomorphic mouse models, FACS analysis, histology, immunostaining","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic loss-of-function with defined cellular phenotypes, multiple readouts","pmids":["18669443"],"is_preprint":false},{"year":2009,"finding":"DAZAP1 interacts with several RNA-binding proteins (beyond DAZ) via its RNA recognition motifs (RRMs) binding to the C-termini of these partners, in a phosphorylation-independent manner, suggesting DAZAP1 is part of complexes involved in mRNA degradation and silencing.","method":"Co-immunoprecipitation, binding domain mapping","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 — single study, single method (Co-IP), limited functional follow-up","pmids":["19285026"],"is_preprint":false},{"year":2011,"finding":"DAZAP1 (Xenopus and human) acts as a mRNA-specific translational activator by stimulating translation initiation in a cap-independent manner downstream of 5' cap recognition; this activity is modulated by poly(A) tail length and is associated with formation of end-to-end mRNA complexes but does not require direct interaction with eIF4G; domain mapping places this activity in C-terminal regions.","method":"In vitro translation assay with reporter mRNAs, IRES constructs, domain mapping/mutagenesis, polysome association assays","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with multiple reporter systems and domain mapping","pmids":["21576381"],"is_preprint":false},{"year":2011,"finding":"DAZAP1 binds to an Alu-derived intronic splicing enhancer (ISE) in the ATM gene and positively regulates ISE-dependent inclusion of an ATM cryptic exon, as demonstrated by RNA pulldown and siRNA functional experiments.","method":"RNA pulldown assay, siRNA knockdown, overexpression, minigene splicing assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — pulldown plus siRNA/overexpression functional validation","pmids":["21858080"],"is_preprint":false},{"year":2012,"finding":"A 42-amino acid N-terminal segment (N42) of DAZAP1 is necessary and sufficient for its transcription-dependent nuclear localization; SLIRP was identified as an N42-binding protein that may regulate DAZAP1 subcellular localization.","method":"Domain deletion/mutagenesis, immunostaining, yeast two-hybrid","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional localization readout in single study","pmids":["23111326"],"is_preprint":false},{"year":2013,"finding":"DAZAP1 promotes inclusion of specific exons (Crem exon 4, Crisp2 exon 9, Pot1a exon 4) by binding to regulatory sequences in their downstream introns, as demonstrated in DAZAP1-deficient mouse testes (microarray) and splicing reporter assays; DAZAP1 mutant proteins lacking this activity fail to rescue exon inclusion.","method":"Exon microarray on Dazap1 mutant testes, minigene splicing reporters, RNA-binding assays, mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo knockout plus in vitro minigene plus RNA binding, multiple targets","pmids":["23965306"],"is_preprint":false},{"year":2013,"finding":"The two Dazap1 transcripts (generated by alternative polyadenylation) are differentially translated during spermatogenesis; DAZL binds preferentially to the 3'UTR of the long Dazap1-L transcript and stimulates its translation; the short Dazap1-S is translationally repressed and sequestered to mRNPs with elongated poly(A) tails.","method":"Northern blot, 3' RACE, sucrose gradient/polysome analysis, RNA pulldown + mass spectrometry, luciferase reporter assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including biochemical fractionation, pulldown-MS, and reporter assay","pmids":["23658607"],"is_preprint":false},{"year":2014,"finding":"DAZAP1 promotes inclusion of weak exons by recognizing diverse cis-elements; its C-terminal proline-rich domain interacts with and neutralizes general splicing inhibitors and is sufficient to activate splicing when tethered to pre-mRNA; MEK/ERK phosphorylation of this domain is essential for splicing regulatory activity and controls nuclear/cytoplasmic translocation of DAZAP1; DAZAP1 regulates endogenous splicing events involved in cell growth, and its knockdown or overexpression causes a cell proliferation defect.","method":"Minigene splicing reporters, domain mapping/mutagenesis, tethering assay, MEK/ERK inhibitor experiments, mRNA-seq, siRNA knockdown, overexpression, cell proliferation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (tethering, mutagenesis, mRNA-seq, inhibitors, KD/OE) in single high-impact study","pmids":["24452013"],"is_preprint":false},{"year":2018,"finding":"DAZAP1 binds to cox6c mRNA in an intron-dependent manner (last intron sufficient for loading), reduces pre-mRNA splicing efficiency, and thereby negatively regulates COX6C protein levels; overexpression of DAZAP1 leads to accumulation of cox6c pre-mRNA.","method":"RIP (RNA immunoprecipitation), intron deletion constructs, qRT-PCR, Western blot, overexpression","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — RIP plus functional deletion constructs in single study","pmids":["29505834"],"is_preprint":false},{"year":2020,"finding":"DAZAP1 binds to the 3'UTR of SLC7A11 mRNA and positively regulates its stability, thereby inhibiting ferroptosis in HCC cells; DAZAP1 knockdown reduces SLC7A11 levels and sensitizes cells to sorafenib-induced ferroptosis.","method":"RNA immunoprecipitation (RIP), siRNA knockdown, mRNA stability assay, ferroptosis assays, Western blot","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 — RIP plus functional KD with ferroptosis readout","pmids":["33358859"],"is_preprint":false},{"year":2020,"finding":"DAZAP1 regulates alternative splicing of TSC2, promoting inclusion of exon 26; DAZAP1 silencing produces a short TSC2 isoform that cannot be phosphorylated at Ser981 by AKT, leading to constitutive TSC2 activation, RHEB-mediated mTOR inhibition, and enhanced autophagy in ESCC cells; miR-10b suppresses DAZAP1 expression under starvation.","method":"RNAseq, siRNA knockdown, minigene splicing, AKT phosphorylation assay, mTOR pathway analysis, miR-10b overexpression","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 1-2 — RNAseq plus splicing validation plus phosphorylation functional assay, pathway epistasis established","pmids":["32308763"],"is_preprint":false},{"year":2022,"finding":"DAZAP1 activates alternative splicing of KITLG mRNA, and the resulting KITLG isoform increases ERK phosphorylation to promote multiple myeloma cell proliferation.","method":"RIP-seq, RIP-qPCR, lentiviral overexpression, siRNA knockdown, ERK phosphorylation assay, xenograft tumor model","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 — RIP-seq plus functional in vitro and in vivo validation","pmids":["36242590"],"is_preprint":false},{"year":2023,"finding":"DAZAP1 interacts with PXR (pregnane X receptor) and with the lncRNA NEAT1_2 as a paraspeckle component; this interaction traps PXR in paraspeckles and suppresses its transactivation of CYP3A4; PXR ligand (rifampicin) dissociates PXR from DAZAP1 and NEAT1_2, and knockdown of DAZAP1 enhances CYP3A4 induction by rifampicin.","method":"Co-immunoprecipitation, siRNA knockdown, luciferase reporter assay (PXR response elements)","journal":"Drug metabolism and disposition","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus functional reporter and siRNA experiments","pmids":["37349114"],"is_preprint":false},{"year":2024,"finding":"DAZAP1 undergoes liquid-liquid phase separation to accumulate in the nucleus where it regulates alternative splicing of COX16 pre-mRNA, increasing COX16 expression and promoting mitochondrial respiration and OSCC invasion/metastasis.","method":"Phase separation assay, RNA-seq, splicing reporter, DAZAP1 knockdown/overexpression, Seahorse metabolic assay, mouse tumor model","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — phase separation plus splicing validation plus metabolic functional readout","pmids":["39120588"],"is_preprint":false},{"year":2025,"finding":"p52-ZER6 promotes transcriptional activity of DAZAP1, which then binds the 3'-UTR of SLC7A11 mRNA to enhance its stability, increasing SLC7A11 protein, elevating glutathione levels, reducing lipid peroxide accumulation, and conferring ferroptosis resistance in colorectal cancer.","method":"Transcription reporter assay, RNA immunoprecipitation, mRNA stability assay, ferroptosis assays (lipid peroxide, GSH), knockdown/overexpression","journal":"Acta pharmaceutica Sinica. B","confidence":"Medium","confidence_rationale":"Tier 2 — RIP plus mRNA stability plus ferroptosis functional assays","pmids":["40486833"],"is_preprint":false},{"year":2025,"finding":"DAZAP1 binds USP34 mRNA and stabilizes it, leading to increased USP34 protein expression, which mediates deubiquitination and stabilization of PIN1 oncoprotein, activating the MAPK signaling pathway in gastric cancer; DAZAP1 mRNA is itself post-transcriptionally stabilized by the m6A demethylase ALKBH5, protecting it from YTHDF2-mediated degradation.","method":"RNA immunoprecipitation, mRNA stability assay, co-immunoprecipitation, ubiquitination assay, m6A detection, siRNA/overexpression, in vivo xenograft","journal":"Cell biology and toxicology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical assays establishing the regulatory axis in single study","pmids":["41331184"],"is_preprint":false},{"year":2025,"finding":"DAZAP1 regulates splicing and expression of the mitophagy-related gene ULK1 through nonsense-mediated mRNA decay, thereby activating mitophagy and enhancing oxidative phosphorylation to support gastric cancer stem cell maintenance.","method":"RNA immunoprecipitation, PCR-based splicing analysis, Seahorse assay, sphere formation assay, transmission electron microscopy, immunofluorescence, rescue experiments (ULK1 overexpression)","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 — RIP plus multiple functional readouts and rescue experiment","pmids":["40401521"],"is_preprint":false},{"year":2026,"finding":"DAZAP1 physically binds NOTCH1 and JAG1 mRNAs to enhance their stability, activating the NOTCH/JAG1 signaling pathway and promoting EMT-mediated migration and invasion of gastric cancer cells.","method":"RNA immunoprecipitation (RIP-seq and RIP-qPCR), mRNA stability assay, knockdown/overexpression, migration/invasion assays","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 — RIP-seq plus stability assay plus functional cellular readouts","pmids":["41789621"],"is_preprint":false}],"current_model":"DAZAP1 is a nucleocytoplasmic-shuttling hnRNP/RNA-binding protein that (1) promotes inclusion of weak exons in pre-mRNA splicing by binding intronic regulatory elements and neutralizing splicing inhibitors via its C-terminal proline-rich domain, (2) acts as a mRNA-specific translational activator by stimulating cap-independent initiation, (3) stabilizes specific target mRNAs (e.g., SLC7A11, USP34, NOTCH1/JAG1) by binding their 3'-UTRs, (4) is phosphorylated by ERK1/2 at Thr269/Thr315, which is required for its splicing activity and controls nuclear/cytoplasmic localization and dissociation from DAZ, and (5) undergoes liquid-liquid phase separation to concentrate in the nucleus, collectively placing DAZAP1 at the intersection of the MEK/ERK signaling pathway, pre-mRNA alternative splicing, mRNA stability, and translational regulation in both germ cells and somatic/cancer cells."},"narrative":{"teleology":[{"year":2001,"claim":"Identifying DAZAP1 as a DAZ/DAZL-interacting RNA-binding protein established its molecular identity and linked it to germ cell biology.","evidence":"Yeast two-hybrid and in vitro binding with DAZ/DAZL; domain mapping revealed two RBDs and a proline-rich C-terminus","pmids":["11604102"],"confidence":"Medium","gaps":["No endogenous function demonstrated","RNA targets unknown","Interaction with DAZ not validated in vivo"]},{"year":2006,"claim":"Discovery that DAZAP1 is an hnRNP component that shuttles between nucleus and cytoplasm via a C-terminal signal, dependent on active transcription, defined its subcellular dynamics and placed it among spliceosome-associated factors.","evidence":"Heterokaryon assay, actinomycin D treatment, GFP-fusion mutagenesis identifying a 25-aa nuclear-shuttling signal; co-localization with hnRNP A1/C1","pmids":["16772659"],"confidence":"High","gaps":["Cargo RNA identity during shuttling unknown","Whether shuttling is regulated by signaling not addressed"]},{"year":2006,"claim":"Demonstrating ERK2-mediated phosphorylation at Thr269/Thr315 that controls DAZ dissociation connected DAZAP1 to MAPK signaling and suggested a regulatory switch for its activity.","evidence":"In vitro kinase assay with ERK2, phospho-mimetic mutants, MEK inhibitors (PD184352, U0126), co-immunoprecipitation showing phosphorylation-dependent DAZ release","pmids":["16848763"],"confidence":"High","gaps":["In vivo phosphorylation kinetics uncharacterized","Downstream consequences of DAZ dissociation on RNA metabolism unknown"]},{"year":2008,"claim":"Genetic loss-of-function in mice proved DAZAP1 is essential for spermatogenesis and normal growth, establishing it as a non-redundant regulator of germ cell development.","evidence":"Knockout/hypomorphic mouse models with FACS, histology, and immunostaining showing pre-meiotic spermatogenic arrest and growth retardation","pmids":["18669443"],"confidence":"High","gaps":["Molecular targets responsible for meiotic arrest not identified","Female infertility mechanism not resolved"]},{"year":2008,"claim":"Identification of DAZAP1 binding to a BRCA1 exonic splicing silencer provided the first direct evidence for its role in splicing regulation.","evidence":"RNA pulldown, siRNA knockdown, and minigene reporter for BRCA1 exon 18 skipping","pmids":["18391021"],"confidence":"High","gaps":["Genome-wide splicing targets unknown","Whether DAZAP1 is activator or repressor in general context unclear"]},{"year":2011,"claim":"Reconstitution of DAZAP1's translational activity showed it stimulates cap-independent translation initiation, expanding its functions beyond splicing to translational control.","evidence":"In vitro translation with reporter mRNAs, IRES constructs, domain mapping showing C-terminal activity, polysome association","pmids":["21576381"],"confidence":"High","gaps":["In vivo translational targets not identified","Mechanism of cap-independent stimulation not structurally resolved"]},{"year":2013,"claim":"Combining Dazap1-mutant transcriptomics with minigene reporters demonstrated that DAZAP1 promotes weak exon inclusion by binding downstream intronic elements, defining its general splicing-activation mechanism.","evidence":"Exon microarray on mutant mouse testes identifying Crem, Crisp2, Pot1a targets; minigene reporters; RNA-binding assays with mutant proteins","pmids":["23965306"],"confidence":"High","gaps":["Full RNA binding motif not defined","How intronic binding leads to exon recognition mechanistically unclear"]},{"year":2014,"claim":"Tethering and domain-mapping experiments showed the proline-rich domain neutralizes splicing inhibitors and that MEK/ERK phosphorylation of this domain is essential for splicing activity and nuclear localization, unifying signaling control with splicing mechanism.","evidence":"MS2-tethering assay, domain mutagenesis, MEK inhibitor treatment, mRNA-seq, cell proliferation assays","pmids":["24452013"],"confidence":"High","gaps":["Identity of neutralized splicing inhibitors at molecular level unknown","Structural basis of proline-rich domain function unresolved"]},{"year":2020,"claim":"DAZAP1-dependent alternative splicing of TSC2 controlling mTOR/autophagy signaling revealed how a single splicing event by DAZAP1 rewires an entire signaling pathway.","evidence":"RNA-seq, minigene, AKT phosphorylation and mTOR pathway analysis in ESCC cells with DAZAP1 silencing","pmids":["32308763"],"confidence":"High","gaps":["Whether TSC2 splicing regulation is direct or indirect not fully resolved","Generality across cell types untested"]},{"year":2020,"claim":"Showing DAZAP1 stabilizes SLC7A11 mRNA via 3′-UTR binding to inhibit ferroptosis established a direct mRNA stabilization function with disease relevance beyond splicing.","evidence":"RIP, siRNA knockdown, mRNA stability and ferroptosis assays in HCC cells","pmids":["33358859"],"confidence":"Medium","gaps":["Binding site on SLC7A11 3′-UTR not mapped","Mechanism of stabilization (deadenylase blockade vs. other) unknown"]},{"year":2024,"claim":"Discovery of DAZAP1 liquid–liquid phase separation as a mechanism for its nuclear concentration and splicing regulation introduced a biophysical dimension to its function.","evidence":"In vitro and cellular phase separation assays, RNA-seq showing COX16 splicing regulation, Seahorse metabolic assay in OSCC","pmids":["39120588"],"confidence":"Medium","gaps":["Phase separation determinants (IDR residues) not mapped","Whether phase separation is regulated by ERK phosphorylation untested","Single cancer type studied"]},{"year":2025,"claim":"Multiple studies converged to show DAZAP1 stabilizes diverse oncogenic mRNAs (USP34, NOTCH1, JAG1) and is itself regulated by ALKBH5-mediated m6A demethylation, embedding DAZAP1 in epitranscriptomic and oncogenic signaling networks.","evidence":"RIP-seq, mRNA stability assays, m6A detection, ubiquitination assays, xenograft models in gastric and colorectal cancer","pmids":["41331184","41789621","40486833"],"confidence":"Medium","gaps":["Genome-wide map of DAZAP1-stabilized mRNAs not available","Relative contribution of splicing vs. stability functions in cancer unclear","No structural basis for 3′-UTR recognition"]},{"year":null,"claim":"Key unresolved questions include the structural basis of DAZAP1's RNA recognition specificity, the full catalog of its RNA targets across tissues, how phase separation intersects with ERK-dependent phosphorylation, and whether its splicing and stability functions are coordinated or independently regulated.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure available","No CLIP-seq or eCLIP binding map across cell types","Relationship between phase separation and phosphorylation untested","Relative importance of splicing vs. mRNA stability in germ cells unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,3,7,10,11,13,15,17,23,25]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[7,11,13,15,18,21,24]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[15,18,20]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,9]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,5,12,21]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[5,15,21]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[7,11,13,15,18,21,24]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[13,15,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,15,18,19]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[10,14,17,23,25]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[18,24]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[8,14]}],"complexes":["hnRNP particles","paraspeckles"],"partners":["DAZ","DAZL","SLIRP","PXR","HNRNPA1","ERK2"],"other_free_text":[]},"mechanistic_narrative":"DAZAP1 is a nucleocytoplasmic-shuttling hnRNP protein that functions as a pleiotropic post-transcriptional regulator of gene expression through alternative splicing, mRNA stabilization, and translational control. It promotes inclusion of weak exons by binding intronic regulatory elements and using its C-terminal proline-rich domain to neutralize splicing inhibitors; this splicing activity requires MEK/ERK-dependent phosphorylation at Thr269 and Thr315, which also governs its nuclear–cytoplasmic distribution and dissociation from the germ-cell factor DAZ [PMID:24452013, PMID:16848763]. DAZAP1 stabilizes specific mRNAs—including SLC7A11, USP34, NOTCH1, and JAG1—by binding their 3′-UTRs and acts as an mRNA-specific translational activator that stimulates cap-independent initiation [PMID:21576381, PMID:33358859, PMID:41789621]. Loss of DAZAP1 in mice causes spermatogenic arrest before meiotic division, growth retardation, and female infertility, underscoring its essential role in gametogenesis and somatic cell proliferation [PMID:18669443]."},"prefetch_data":{"uniprot":{"accession":"Q96EP5","full_name":"DAZ-associated protein 1","aliases":["Deleted in azoospermia-associated protein 1"],"length_aa":407,"mass_kda":43.4,"function":"RNA-binding protein, which may be required during spermatogenesis","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96EP5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DAZAP1","classification":"Not Classified","n_dependent_lines":198,"n_total_lines":1208,"dependency_fraction":0.16390728476821192},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DAZAP1","total_profiled":1310},"omim":[{"mim_id":"607431","title":"DAZ-ASSOCIATED PROTEIN 2; DAZAP2","url":"https://www.omim.org/entry/607431"},{"mim_id":"607430","title":"DAZ-ASSOCIATED PROTEIN 1; DAZAP1","url":"https://www.omim.org/entry/607430"},{"mim_id":"601486","title":"DELETED IN AZOOSPERMIA-LIKE; DAZL","url":"https://www.omim.org/entry/601486"},{"mim_id":"400003","title":"DELETED IN AZOOSPERMIA 1; DAZ1","url":"https://www.omim.org/entry/400003"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Midbody","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DAZAP1"},"hgnc":{"alias_symbol":["MGC19907"],"prev_symbol":[]},"alphafold":{"accession":"Q96EP5","domains":[{"cath_id":"3.30.70.330","chopping":"5-83","consensus_level":"high","plddt":89.9368,"start":5,"end":83},{"cath_id":"3.30.70.330","chopping":"113-186","consensus_level":"high","plddt":88.4915,"start":113,"end":186}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EP5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EP5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EP5-F1-predicted_aligned_error_v6.png","plddt_mean":64.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DAZAP1","jax_strain_url":"https://www.jax.org/strain/search?query=DAZAP1"},"sequence":{"accession":"Q96EP5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96EP5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96EP5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EP5"}},"corpus_meta":[{"pmid":"33358859","id":"PMC_33358859","title":"RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33358859","citation_count":79,"is_preprint":false},{"pmid":"18391021","id":"PMC_18391021","title":"Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18391021","citation_count":71,"is_preprint":false},{"pmid":"24452013","id":"PMC_24452013","title":"The splicing activator DAZAP1 integrates splicing control into MEK/Erk-regulated cell proliferation and migration.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24452013","citation_count":51,"is_preprint":false},{"pmid":"15744350","id":"PMC_15744350","title":"Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.","date":"2005","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/15744350","citation_count":47,"is_preprint":false},{"pmid":"18669443","id":"PMC_18669443","title":"DAZAP1, an hnRNP protein, is required for normal growth and spermatogenesis in mice.","date":"2008","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18669443","citation_count":42,"is_preprint":false},{"pmid":"21576381","id":"PMC_21576381","title":"DAZAP1, an RNA-binding protein required for development and spermatogenesis, can regulate mRNA translation.","date":"2011","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/21576381","citation_count":41,"is_preprint":false},{"pmid":"16772659","id":"PMC_16772659","title":"A novel nucleocytoplasmic shuttling sequence of DAZAP1, a testis-abundant RNA-binding protein.","date":"2006","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16772659","citation_count":40,"is_preprint":false},{"pmid":"32308763","id":"PMC_32308763","title":"Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32308763","citation_count":33,"is_preprint":false},{"pmid":"17898785","id":"PMC_17898785","title":"Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia.","date":"2007","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/17898785","citation_count":30,"is_preprint":false},{"pmid":"21858080","id":"PMC_21858080","title":"Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21858080","citation_count":27,"is_preprint":false},{"pmid":"11604102","id":"PMC_11604102","title":"Characterization of the mouse Dazap1 gene encoding an RNA-binding protein that interacts with infertility factors DAZ and DAZL.","date":"2001","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11604102","citation_count":27,"is_preprint":false},{"pmid":"16848763","id":"PMC_16848763","title":"Phosphorylation of the ARE-binding protein DAZAP1 by ERK2 induces its dissociation from DAZ.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16848763","citation_count":26,"is_preprint":false},{"pmid":"19285026","id":"PMC_19285026","title":"DAZAP1 interacts via its RNA-recognition motifs with the C-termini of other RNA-binding proteins.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19285026","citation_count":20,"is_preprint":false},{"pmid":"39120588","id":"PMC_39120588","title":"DAZAP1 Phase Separation Regulates Mitochondrial Metabolism to Facilitate Invasion and Metastasis of Oral Squamous Cell Carcinoma.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/39120588","citation_count":19,"is_preprint":false},{"pmid":"23965306","id":"PMC_23965306","title":"DAZAP1 regulates the splicing of Crem, Crisp2 and Pot1a transcripts.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23965306","citation_count":19,"is_preprint":false},{"pmid":"29505834","id":"PMC_29505834","title":"Specific intron-dependent loading of DAZAP1 onto the cox6c transcript suppresses pre-mRNA splicing efficacy and induces cell growth retardation.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29505834","citation_count":13,"is_preprint":false},{"pmid":"15700540","id":"PMC_15700540","title":"Dynamic changes in intranuclear and subcellular localizations of mouse Prrp/DAZAP1 during spermatogenesis: the necessity of the C-terminal proline-rich region for nuclear import and localization.","date":"2004","source":"Archives of histology and cytology","url":"https://pubmed.ncbi.nlm.nih.gov/15700540","citation_count":13,"is_preprint":false},{"pmid":"37507717","id":"PMC_37507717","title":"MiR-320a upregulation improves IL-1β-induced osteoarthritis via targeting the DAZAP1 and MAPK pathways.","date":"2023","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/37507717","citation_count":10,"is_preprint":false},{"pmid":"23658607","id":"PMC_23658607","title":"Differential translation of Dazap1 transcripts during spermatogenesis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23658607","citation_count":10,"is_preprint":false},{"pmid":"16209998","id":"PMC_16209998","title":"Expression patterns of the DAZ-associated protein DAZAP1 in rat and human ovaries.","date":"2005","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/16209998","citation_count":10,"is_preprint":false},{"pmid":"36242590","id":"PMC_36242590","title":"DAZAP1 facilitates the alternative splicing of KITLG to promote multiple myeloma cell proliferation via ERK signaling pathway.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/36242590","citation_count":9,"is_preprint":false},{"pmid":"35091997","id":"PMC_35091997","title":"DAZAP1 overexpression promotes growth of HCC cell lines: a primary study using CEUS.","date":"2022","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/35091997","citation_count":8,"is_preprint":false},{"pmid":"40486833","id":"PMC_40486833","title":"p52-ZER6/DAZAP1 axis promotes ferroptosis resistance and colorectal cancer progression via regulating SLC7A11 mRNA stabilization.","date":"2025","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/40486833","citation_count":7,"is_preprint":false},{"pmid":"37349114","id":"PMC_37349114","title":"NEAT1_2 and DAZAP1, Paraspeckle Components, Interact with PXR to Negatively Regulate CYP3A4 Induction.","date":"2023","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/37349114","citation_count":5,"is_preprint":false},{"pmid":"40401521","id":"PMC_40401521","title":"DAZAP1 maintains gastric cancer stemness by inducing mitophagy.","date":"2025","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/40401521","citation_count":3,"is_preprint":false},{"pmid":"23111326","id":"PMC_23111326","title":"Transcription-dependent nuclear localization of DAZAP1 requires an N-terminal signal.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23111326","citation_count":3,"is_preprint":false},{"pmid":"39754243","id":"PMC_39754243","title":"RNA-binding protein DAZAP1 accelerates the advancement of pancreatic cancer by inhibiting ferroptosis.","date":"2025","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/39754243","citation_count":1,"is_preprint":false},{"pmid":"40584277","id":"PMC_40584277","title":"An integrated analysis of second- and third-generation transcriptome sequencing technologies reveals the DAZAP1 function in pig testis.","date":"2025","source":"Animal reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/40584277","citation_count":1,"is_preprint":false},{"pmid":"41331184","id":"PMC_41331184","title":"DAZAP1 promotes cancer progression and chemotherapy resistance by stabilizing PIN1 protein in gastric cancer.","date":"2025","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/41331184","citation_count":0,"is_preprint":false},{"pmid":"41789621","id":"PMC_41789621","title":"RNA‑binding protein DAZAP1 promotes gastric cancer metastasis by enhancing NOTCH1 and JAG1 mRNA stability.","date":"2026","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41789621","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":15770,"output_tokens":5828,"usd":0.067365},"stage2":{"model":"claude-opus-4-6","input_tokens":9424,"output_tokens":3090,"usd":0.186555},"total_usd":0.25392,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"DAZAP1 was identified as a protein that interacts with the male infertility factors DAZ and DAZL through yeast two-hybrid and in vitro binding assays; it contains two RNA-binding domains (RBDs) and a proline-rich C-terminal region, and while predominantly cytoplasmic, it is not associated with polyribosomes.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding, subcellular fractionation, Western blot\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in single study, foundational interaction paper\",\n      \"pmids\": [\"11604102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mouse DAZAP1/Prrp shows dynamic intranuclear and subcellular localization changes during spermatogenesis (nuclear in pre-meiotic cells and round spermatids, cytoplasmic in elongating spermatids), and the C-terminal proline-rich region is required for nuclear import.\",\n      \"method\": \"Immunohistochemistry with monoclonal antibody, mutagenesis, subcellular localization assays\",\n      \"journal\": \"Archives of histology and cytology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional mutagenesis in single study\",\n      \"pmids\": [\"15700540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DAZAP1 interacts with DAZL protein in ovarian luteal cells as demonstrated by co-immunoprecipitation from ovarian tissue.\",\n      \"method\": \"Co-immunoprecipitation from rat and human ovarian tissue\",\n      \"journal\": \"Fertility and sterility\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP from tissue, no functional follow-up\",\n      \"pmids\": [\"16209998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The MEF2D/DAZAP1 fusion protein (created by t(1;19) translocation) binds DNA in a manner indistinguishable from native MEF2D and acts as a substantially more potent transcriptional activator than MEF2D; the reciprocal DAZAP1/MEF2D fusion retains sequence-specific RNA-binding activity.\",\n      \"method\": \"DNA-binding assays, transcriptional activation assays, RNA-binding assays in leukemia cell line\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays on fusion proteins in a single study\",\n      \"pmids\": [\"15744350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DAZAP1 is phosphorylated by ERK2 at two Thr-Pro sequences (Thr269 and Thr315) in response to PMA, EGF, or LPS via the MKK1/ERK pathway; phosphorylation at these sites causes DAZAP1 to dissociate from its binding partner DAZ, and DAZ cannot simultaneously bind both DAZAP1 and PABP.\",\n      \"method\": \"In vitro kinase assay with ERK2, site-directed mutagenesis (T269D, T315D), co-immunoprecipitation, inhibitor experiments (PD184352, U0126)\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis plus cellular validation with inhibitors\",\n      \"pmids\": [\"16848763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DAZAP1 shuttles between the nucleus and cytoplasm via a novel 25-amino acid C-terminal segment (ZNS); nuclear localization depends on active RNA polymerase II transcription; DAZAP1 co-localizes with hnRNP A1 and hnRNP C1 and is a component of hnRNP particles.\",\n      \"method\": \"Immunostaining, heterokaryon formation assay, mutagenesis, RNA polymerase II inhibitor (actinomycin D), GFP/DsRed fusion constructs\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (heterokaryon, mutagenesis, inhibitor) in single study\",\n      \"pmids\": [\"16772659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Both MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins transform NIH 3T3 cells (soft agar colony formation); co-expression is synergistic; wild-type DAZAP1 expression enables 3T3 cell proliferation under low serum and suppresses apoptosis.\",\n      \"method\": \"Retroviral gene transfer, soft agar colony formation assay, low-serum proliferation assay, apoptosis assay\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays with defined cellular phenotypes\",\n      \"pmids\": [\"17898785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DAZAP1 binds to a T6 mutant BRCA1 exon 18 sequence that creates an exonic splicing silencer, and siRNA depletion of DAZAP1 reduces skipping of exon 18, demonstrating DAZAP1's role in splicing inhibition at this element alongside hnRNPA1/A2.\",\n      \"method\": \"RNA pulldown assay, siRNA knockdown, minigene splicing reporter, overexpression\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (pulldown, siRNA, minigene) with rigorous controls\",\n      \"pmids\": [\"18391021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DAZAP1 is an hnRNP protein required for normal growth and spermatogenesis in mice; loss-of-function causes spermatogenic arrest before meiotic division (absence of post-meiotic haploid cells), growth retardation, and female infertility; DAZAP1 is excluded from the transcriptionally inactive XY body in pachytene spermatocytes.\",\n      \"method\": \"Knockout/hypomorphic mouse models, FACS analysis, histology, immunostaining\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic loss-of-function with defined cellular phenotypes, multiple readouts\",\n      \"pmids\": [\"18669443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DAZAP1 interacts with several RNA-binding proteins (beyond DAZ) via its RNA recognition motifs (RRMs) binding to the C-termini of these partners, in a phosphorylation-independent manner, suggesting DAZAP1 is part of complexes involved in mRNA degradation and silencing.\",\n      \"method\": \"Co-immunoprecipitation, binding domain mapping\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single study, single method (Co-IP), limited functional follow-up\",\n      \"pmids\": [\"19285026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DAZAP1 (Xenopus and human) acts as a mRNA-specific translational activator by stimulating translation initiation in a cap-independent manner downstream of 5' cap recognition; this activity is modulated by poly(A) tail length and is associated with formation of end-to-end mRNA complexes but does not require direct interaction with eIF4G; domain mapping places this activity in C-terminal regions.\",\n      \"method\": \"In vitro translation assay with reporter mRNAs, IRES constructs, domain mapping/mutagenesis, polysome association assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple reporter systems and domain mapping\",\n      \"pmids\": [\"21576381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DAZAP1 binds to an Alu-derived intronic splicing enhancer (ISE) in the ATM gene and positively regulates ISE-dependent inclusion of an ATM cryptic exon, as demonstrated by RNA pulldown and siRNA functional experiments.\",\n      \"method\": \"RNA pulldown assay, siRNA knockdown, overexpression, minigene splicing assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pulldown plus siRNA/overexpression functional validation\",\n      \"pmids\": [\"21858080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A 42-amino acid N-terminal segment (N42) of DAZAP1 is necessary and sufficient for its transcription-dependent nuclear localization; SLIRP was identified as an N42-binding protein that may regulate DAZAP1 subcellular localization.\",\n      \"method\": \"Domain deletion/mutagenesis, immunostaining, yeast two-hybrid\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional localization readout in single study\",\n      \"pmids\": [\"23111326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DAZAP1 promotes inclusion of specific exons (Crem exon 4, Crisp2 exon 9, Pot1a exon 4) by binding to regulatory sequences in their downstream introns, as demonstrated in DAZAP1-deficient mouse testes (microarray) and splicing reporter assays; DAZAP1 mutant proteins lacking this activity fail to rescue exon inclusion.\",\n      \"method\": \"Exon microarray on Dazap1 mutant testes, minigene splicing reporters, RNA-binding assays, mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo knockout plus in vitro minigene plus RNA binding, multiple targets\",\n      \"pmids\": [\"23965306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The two Dazap1 transcripts (generated by alternative polyadenylation) are differentially translated during spermatogenesis; DAZL binds preferentially to the 3'UTR of the long Dazap1-L transcript and stimulates its translation; the short Dazap1-S is translationally repressed and sequestered to mRNPs with elongated poly(A) tails.\",\n      \"method\": \"Northern blot, 3' RACE, sucrose gradient/polysome analysis, RNA pulldown + mass spectrometry, luciferase reporter assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including biochemical fractionation, pulldown-MS, and reporter assay\",\n      \"pmids\": [\"23658607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DAZAP1 promotes inclusion of weak exons by recognizing diverse cis-elements; its C-terminal proline-rich domain interacts with and neutralizes general splicing inhibitors and is sufficient to activate splicing when tethered to pre-mRNA; MEK/ERK phosphorylation of this domain is essential for splicing regulatory activity and controls nuclear/cytoplasmic translocation of DAZAP1; DAZAP1 regulates endogenous splicing events involved in cell growth, and its knockdown or overexpression causes a cell proliferation defect.\",\n      \"method\": \"Minigene splicing reporters, domain mapping/mutagenesis, tethering assay, MEK/ERK inhibitor experiments, mRNA-seq, siRNA knockdown, overexpression, cell proliferation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (tethering, mutagenesis, mRNA-seq, inhibitors, KD/OE) in single high-impact study\",\n      \"pmids\": [\"24452013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DAZAP1 binds to cox6c mRNA in an intron-dependent manner (last intron sufficient for loading), reduces pre-mRNA splicing efficiency, and thereby negatively regulates COX6C protein levels; overexpression of DAZAP1 leads to accumulation of cox6c pre-mRNA.\",\n      \"method\": \"RIP (RNA immunoprecipitation), intron deletion constructs, qRT-PCR, Western blot, overexpression\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP plus functional deletion constructs in single study\",\n      \"pmids\": [\"29505834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DAZAP1 binds to the 3'UTR of SLC7A11 mRNA and positively regulates its stability, thereby inhibiting ferroptosis in HCC cells; DAZAP1 knockdown reduces SLC7A11 levels and sensitizes cells to sorafenib-induced ferroptosis.\",\n      \"method\": \"RNA immunoprecipitation (RIP), siRNA knockdown, mRNA stability assay, ferroptosis assays, Western blot\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP plus functional KD with ferroptosis readout\",\n      \"pmids\": [\"33358859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DAZAP1 regulates alternative splicing of TSC2, promoting inclusion of exon 26; DAZAP1 silencing produces a short TSC2 isoform that cannot be phosphorylated at Ser981 by AKT, leading to constitutive TSC2 activation, RHEB-mediated mTOR inhibition, and enhanced autophagy in ESCC cells; miR-10b suppresses DAZAP1 expression under starvation.\",\n      \"method\": \"RNAseq, siRNA knockdown, minigene splicing, AKT phosphorylation assay, mTOR pathway analysis, miR-10b overexpression\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — RNAseq plus splicing validation plus phosphorylation functional assay, pathway epistasis established\",\n      \"pmids\": [\"32308763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DAZAP1 activates alternative splicing of KITLG mRNA, and the resulting KITLG isoform increases ERK phosphorylation to promote multiple myeloma cell proliferation.\",\n      \"method\": \"RIP-seq, RIP-qPCR, lentiviral overexpression, siRNA knockdown, ERK phosphorylation assay, xenograft tumor model\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP-seq plus functional in vitro and in vivo validation\",\n      \"pmids\": [\"36242590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DAZAP1 interacts with PXR (pregnane X receptor) and with the lncRNA NEAT1_2 as a paraspeckle component; this interaction traps PXR in paraspeckles and suppresses its transactivation of CYP3A4; PXR ligand (rifampicin) dissociates PXR from DAZAP1 and NEAT1_2, and knockdown of DAZAP1 enhances CYP3A4 induction by rifampicin.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, luciferase reporter assay (PXR response elements)\",\n      \"journal\": \"Drug metabolism and disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus functional reporter and siRNA experiments\",\n      \"pmids\": [\"37349114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DAZAP1 undergoes liquid-liquid phase separation to accumulate in the nucleus where it regulates alternative splicing of COX16 pre-mRNA, increasing COX16 expression and promoting mitochondrial respiration and OSCC invasion/metastasis.\",\n      \"method\": \"Phase separation assay, RNA-seq, splicing reporter, DAZAP1 knockdown/overexpression, Seahorse metabolic assay, mouse tumor model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — phase separation plus splicing validation plus metabolic functional readout\",\n      \"pmids\": [\"39120588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"p52-ZER6 promotes transcriptional activity of DAZAP1, which then binds the 3'-UTR of SLC7A11 mRNA to enhance its stability, increasing SLC7A11 protein, elevating glutathione levels, reducing lipid peroxide accumulation, and conferring ferroptosis resistance in colorectal cancer.\",\n      \"method\": \"Transcription reporter assay, RNA immunoprecipitation, mRNA stability assay, ferroptosis assays (lipid peroxide, GSH), knockdown/overexpression\",\n      \"journal\": \"Acta pharmaceutica Sinica. B\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP plus mRNA stability plus ferroptosis functional assays\",\n      \"pmids\": [\"40486833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DAZAP1 binds USP34 mRNA and stabilizes it, leading to increased USP34 protein expression, which mediates deubiquitination and stabilization of PIN1 oncoprotein, activating the MAPK signaling pathway in gastric cancer; DAZAP1 mRNA is itself post-transcriptionally stabilized by the m6A demethylase ALKBH5, protecting it from YTHDF2-mediated degradation.\",\n      \"method\": \"RNA immunoprecipitation, mRNA stability assay, co-immunoprecipitation, ubiquitination assay, m6A detection, siRNA/overexpression, in vivo xenograft\",\n      \"journal\": \"Cell biology and toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical assays establishing the regulatory axis in single study\",\n      \"pmids\": [\"41331184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DAZAP1 regulates splicing and expression of the mitophagy-related gene ULK1 through nonsense-mediated mRNA decay, thereby activating mitophagy and enhancing oxidative phosphorylation to support gastric cancer stem cell maintenance.\",\n      \"method\": \"RNA immunoprecipitation, PCR-based splicing analysis, Seahorse assay, sphere formation assay, transmission electron microscopy, immunofluorescence, rescue experiments (ULK1 overexpression)\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP plus multiple functional readouts and rescue experiment\",\n      \"pmids\": [\"40401521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DAZAP1 physically binds NOTCH1 and JAG1 mRNAs to enhance their stability, activating the NOTCH/JAG1 signaling pathway and promoting EMT-mediated migration and invasion of gastric cancer cells.\",\n      \"method\": \"RNA immunoprecipitation (RIP-seq and RIP-qPCR), mRNA stability assay, knockdown/overexpression, migration/invasion assays\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP-seq plus stability assay plus functional cellular readouts\",\n      \"pmids\": [\"41789621\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DAZAP1 is a nucleocytoplasmic-shuttling hnRNP/RNA-binding protein that (1) promotes inclusion of weak exons in pre-mRNA splicing by binding intronic regulatory elements and neutralizing splicing inhibitors via its C-terminal proline-rich domain, (2) acts as a mRNA-specific translational activator by stimulating cap-independent initiation, (3) stabilizes specific target mRNAs (e.g., SLC7A11, USP34, NOTCH1/JAG1) by binding their 3'-UTRs, (4) is phosphorylated by ERK1/2 at Thr269/Thr315, which is required for its splicing activity and controls nuclear/cytoplasmic localization and dissociation from DAZ, and (5) undergoes liquid-liquid phase separation to concentrate in the nucleus, collectively placing DAZAP1 at the intersection of the MEK/ERK signaling pathway, pre-mRNA alternative splicing, mRNA stability, and translational regulation in both germ cells and somatic/cancer cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DAZAP1 is a nucleocytoplasmic-shuttling hnRNP protein that functions as a pleiotropic post-transcriptional regulator of gene expression through alternative splicing, mRNA stabilization, and translational control. It promotes inclusion of weak exons by binding intronic regulatory elements and using its C-terminal proline-rich domain to neutralize splicing inhibitors; this splicing activity requires MEK/ERK-dependent phosphorylation at Thr269 and Thr315, which also governs its nuclear–cytoplasmic distribution and dissociation from the germ-cell factor DAZ [PMID:24452013, PMID:16848763]. DAZAP1 stabilizes specific mRNAs—including SLC7A11, USP34, NOTCH1, and JAG1—by binding their 3′-UTRs and acts as an mRNA-specific translational activator that stimulates cap-independent initiation [PMID:21576381, PMID:33358859, PMID:41789621]. Loss of DAZAP1 in mice causes spermatogenic arrest before meiotic division, growth retardation, and female infertility, underscoring its essential role in gametogenesis and somatic cell proliferation [PMID:18669443].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying DAZAP1 as a DAZ/DAZL-interacting RNA-binding protein established its molecular identity and linked it to germ cell biology.\",\n      \"evidence\": \"Yeast two-hybrid and in vitro binding with DAZ/DAZL; domain mapping revealed two RBDs and a proline-rich C-terminus\",\n      \"pmids\": [\"11604102\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No endogenous function demonstrated\", \"RNA targets unknown\", \"Interaction with DAZ not validated in vivo\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that DAZAP1 is an hnRNP component that shuttles between nucleus and cytoplasm via a C-terminal signal, dependent on active transcription, defined its subcellular dynamics and placed it among spliceosome-associated factors.\",\n      \"evidence\": \"Heterokaryon assay, actinomycin D treatment, GFP-fusion mutagenesis identifying a 25-aa nuclear-shuttling signal; co-localization with hnRNP A1/C1\",\n      \"pmids\": [\"16772659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cargo RNA identity during shuttling unknown\", \"Whether shuttling is regulated by signaling not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating ERK2-mediated phosphorylation at Thr269/Thr315 that controls DAZ dissociation connected DAZAP1 to MAPK signaling and suggested a regulatory switch for its activity.\",\n      \"evidence\": \"In vitro kinase assay with ERK2, phospho-mimetic mutants, MEK inhibitors (PD184352, U0126), co-immunoprecipitation showing phosphorylation-dependent DAZ release\",\n      \"pmids\": [\"16848763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo phosphorylation kinetics uncharacterized\", \"Downstream consequences of DAZ dissociation on RNA metabolism unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic loss-of-function in mice proved DAZAP1 is essential for spermatogenesis and normal growth, establishing it as a non-redundant regulator of germ cell development.\",\n      \"evidence\": \"Knockout/hypomorphic mouse models with FACS, histology, and immunostaining showing pre-meiotic spermatogenic arrest and growth retardation\",\n      \"pmids\": [\"18669443\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets responsible for meiotic arrest not identified\", \"Female infertility mechanism not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of DAZAP1 binding to a BRCA1 exonic splicing silencer provided the first direct evidence for its role in splicing regulation.\",\n      \"evidence\": \"RNA pulldown, siRNA knockdown, and minigene reporter for BRCA1 exon 18 skipping\",\n      \"pmids\": [\"18391021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide splicing targets unknown\", \"Whether DAZAP1 is activator or repressor in general context unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Reconstitution of DAZAP1's translational activity showed it stimulates cap-independent translation initiation, expanding its functions beyond splicing to translational control.\",\n      \"evidence\": \"In vitro translation with reporter mRNAs, IRES constructs, domain mapping showing C-terminal activity, polysome association\",\n      \"pmids\": [\"21576381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo translational targets not identified\", \"Mechanism of cap-independent stimulation not structurally resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Combining Dazap1-mutant transcriptomics with minigene reporters demonstrated that DAZAP1 promotes weak exon inclusion by binding downstream intronic elements, defining its general splicing-activation mechanism.\",\n      \"evidence\": \"Exon microarray on mutant mouse testes identifying Crem, Crisp2, Pot1a targets; minigene reporters; RNA-binding assays with mutant proteins\",\n      \"pmids\": [\"23965306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full RNA binding motif not defined\", \"How intronic binding leads to exon recognition mechanistically unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Tethering and domain-mapping experiments showed the proline-rich domain neutralizes splicing inhibitors and that MEK/ERK phosphorylation of this domain is essential for splicing activity and nuclear localization, unifying signaling control with splicing mechanism.\",\n      \"evidence\": \"MS2-tethering assay, domain mutagenesis, MEK inhibitor treatment, mRNA-seq, cell proliferation assays\",\n      \"pmids\": [\"24452013\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of neutralized splicing inhibitors at molecular level unknown\", \"Structural basis of proline-rich domain function unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"DAZAP1-dependent alternative splicing of TSC2 controlling mTOR/autophagy signaling revealed how a single splicing event by DAZAP1 rewires an entire signaling pathway.\",\n      \"evidence\": \"RNA-seq, minigene, AKT phosphorylation and mTOR pathway analysis in ESCC cells with DAZAP1 silencing\",\n      \"pmids\": [\"32308763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TSC2 splicing regulation is direct or indirect not fully resolved\", \"Generality across cell types untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing DAZAP1 stabilizes SLC7A11 mRNA via 3′-UTR binding to inhibit ferroptosis established a direct mRNA stabilization function with disease relevance beyond splicing.\",\n      \"evidence\": \"RIP, siRNA knockdown, mRNA stability and ferroptosis assays in HCC cells\",\n      \"pmids\": [\"33358859\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding site on SLC7A11 3′-UTR not mapped\", \"Mechanism of stabilization (deadenylase blockade vs. other) unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery of DAZAP1 liquid–liquid phase separation as a mechanism for its nuclear concentration and splicing regulation introduced a biophysical dimension to its function.\",\n      \"evidence\": \"In vitro and cellular phase separation assays, RNA-seq showing COX16 splicing regulation, Seahorse metabolic assay in OSCC\",\n      \"pmids\": [\"39120588\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phase separation determinants (IDR residues) not mapped\", \"Whether phase separation is regulated by ERK phosphorylation untested\", \"Single cancer type studied\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Multiple studies converged to show DAZAP1 stabilizes diverse oncogenic mRNAs (USP34, NOTCH1, JAG1) and is itself regulated by ALKBH5-mediated m6A demethylation, embedding DAZAP1 in epitranscriptomic and oncogenic signaling networks.\",\n      \"evidence\": \"RIP-seq, mRNA stability assays, m6A detection, ubiquitination assays, xenograft models in gastric and colorectal cancer\",\n      \"pmids\": [\"41331184\", \"41789621\", \"40486833\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genome-wide map of DAZAP1-stabilized mRNAs not available\", \"Relative contribution of splicing vs. stability functions in cancer unclear\", \"No structural basis for 3′-UTR recognition\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of DAZAP1's RNA recognition specificity, the full catalog of its RNA targets across tissues, how phase separation intersects with ERK-dependent phosphorylation, and whether its splicing and stability functions are coordinated or independently regulated.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure available\", \"No CLIP-seq or eCLIP binding map across cell types\", \"Relationship between phase separation and phosphorylation untested\", \"Relative importance of splicing vs. mRNA stability in germ cells unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 3, 7, 10, 11, 13, 15, 17, 23, 25]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [7, 11, 13, 15, 18, 21, 24]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [15, 18, 20]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 5, 12, 21]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [5, 15, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [7, 11, 13, 15, 18, 21, 24]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [13, 15, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 15, 18, 19]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [10, 14, 17, 23, 25]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [18, 24]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [8, 14]}\n    ],\n    \"complexes\": [\n      \"hnRNP particles\",\n      \"paraspeckles\"\n    ],\n    \"partners\": [\n      \"DAZ\",\n      \"DAZL\",\n      \"SLIRP\",\n      \"PXR\",\n      \"hnRNPA1\",\n      \"ERK2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}